Appearance and disappearance of the mRNA signature characteristic of Treg cells in visceral adipose tissue: Age, diet, and PPARγ effects

D Cipolletta, P Cohen… - Proceedings of the …, 2015 - National Acad Sciences
D Cipolletta, P Cohen, BM Spiegelman, C Benoist, D Mathis
Proceedings of the National Academy of Sciences, 2015National Acad Sciences
A unique population of Foxp3+ CD4+ regulatory T (Treg) cells resides in visceral adipose
tissue (VAT) of lean mice, especially in the epididymal fat depot. VAT Tregs are unusual in
their very high representation within the CD4+ T-cell compartment, their transcriptome, and
their repertoire of antigen-specific T-cell receptors. They are important regulators of local
and systemic inflammation and metabolism. The overall goal of this study was to learn how
the VAT Treg transcriptome adapts to different stimuli; in particular, its response to aging in …
A unique population of Foxp3+CD4+ regulatory T (Treg) cells resides in visceral adipose tissue (VAT) of lean mice, especially in the epididymal fat depot. VAT Tregs are unusual in their very high representation within the CD4+ T-cell compartment, their transcriptome, and their repertoire of antigen-specific T-cell receptors. They are important regulators of local and systemic inflammation and metabolism. The overall goal of this study was to learn how the VAT Treg transcriptome adapts to different stimuli; in particular, its response to aging in lean mice, to metabolic perturbations associated with obesity, and to certain signaling events routed through PPARγ, the “master-regulator” of adipocyte differentiation. We show that the VAT Treg signature is imposed early in life, well before age-dependent expansion of the adipose-tissue Treg population. VAT Tregs in obese mice lose the signature typical of lean individuals but gain an additional set of over- and underrepresented transcripts. This obese mouse VAT Treg signature depends on phosphorylation of the serine residue at position 273 of PPARγ, in striking parallel to a pathway recently elucidated in adipocytes. These findings are important to consider in designing drugs to target type 2 diabetes and other features of the “metabolic syndrome.”
National Acad Sciences